The acute phase response in Syrian hamsters elevates apolipoprotein serum amyloid A (apoSAA) and disrupts lipoprotein metabolism

References

• Pepys M B, Baltz M L. Acute phase proteins with special reference to C-reactive protein and related proteins (pentraxins) and serum amyloid. Adv Immunol 1983; 34: 141–212
   PubMed Web of Science ®Google Scholar
• Grunfeld C, Memon R A, Rapp J H, Feingold K R. Regulation of hepatic lipid metabolism by cytokines that induce the acute phase response. Folia Histochem Cytobiol 1992; 30: 201–202
   PubMed Web of Science ®Google Scholar
• Hayes K C, Lim M, Pronczuk A, Sipe J D. Disruption in lipoprotein metabolism during the acute phase response in hamsters. FASEB J 1991; 5: A1287, Abstr
   Web of Science ®Google Scholar
• Gonnerman W A, Cathcart E S, Sipe J D. Increased binding of acute phase lipoproteins by peritoneal macrophages (Mfs) in mice. (1990). Amyloid and Amyloidosis 1990, J Natvig, O Forre, G Husby, A Husebekk, B Skogen, K Sletten, P Westermark. Kluwer Academic Publishers, Lon-don 1990; 547–550
   Google Scholar
• Kisilevsky R, Subrahmanyan L. Serum amyloid A changes high density lipoprotein's cellular affinity. A clue to serum amyloid A's principal function. Lab Invest 1992; 66: 778–785
   PubMed Web of Science ®Google Scholar
• McAdam KPWJ, Sipe J D. Murine model for human secondary amyloidosis. Genetic variability of the acute phase response to endotoxins and casein. J Exp Med 1976; 144: 1121–1127
   PubMed Web of Science ®Google Scholar
• Benson M D., Scheinberg M A, Shirahama T, Cathcart E S, Skinner M. Kinetics of serum amyloid protein A in casein-induced murine amyloidosis. J Clin Invest 1977; 59: 412–417
   PubMed Web of Science ®Google Scholar
• Sipe J D, Vogel S N, Sztein M B, Skinner M, Cohen A S. The role of interleukin 1 in acute phase serum amyloid A (SAA) and serum amyloid P (SAP) biosynthesis. Ann New York Acad Sci 1982; 389: 137–150
   PubMed Web of Science ®Google Scholar
• Linke R P, Sipe J D, Pollock P S, Ignacazak T F, Glenner G G. Isolation of low-molecular-weight serum component antigenically related to an amyloid fibril protein of unknown origin. Proc Natl Acad Sci USA 1975; 72: 1473–1476
   PubMed Web of Science ®Google Scholar
• Dwulet F E, Benson M D. Primary structure of amyloid fibril protein AA in azocasein-induced amyloidosis in CBA/J mice. J Lab Clin Med 1987; 110: 322–329
   PubMed Web of Science ®Google Scholar
• Hoffman J S, Ericksson L H, Eriksen N, Walsh K A, Benditt E P. Murine tissue amyloid protein AA: NH2-terminal sequence identity with only one of two serum amyloid proteins (apoSAA) gene products. J Exp Med 1984; 159: 641–646
   PubMed Web of Science ®Google Scholar
• Benditt E, Erikson N. Amyloid protein SAA is associated with high density lipoproteins in human serum. Proc Natl Acad Sci USA 1977; 74: 4025–4038
   PubMed Web of Science ®Google Scholar
• Coetzee E P, Strachan A F, van der Westhuyzen D R, Hoppe H, Jeenah M S, de Beer F C. Serum amyloid A-containing human high density lipoprotein 3. J Biol Chem 1986; 261: 9644–9651
   PubMed Web of Science ®Google Scholar
• Benditt E P, Eriksen N, Hanson R H. Amyloid protein SAA is an apoprotein of mouse plasma high density lipoprotein. Proc Natl Acad Sci USA 1979; 76: 4092–4096
   PubMed Web of Science ®Google Scholar
• Baltz M L, Rowe I F, Caspi D, Turnell W G, Pepys M B. Acute phase high-density lipoprotein in the rat does not contain serum amyloid A protein. Biochem J 1987; 242: 301–303
   PubMed Web of Science ®Google Scholar
• de Beer M C, de Beer F C, Beach C M, Gonnerman W A, Carreras I, Sipe J D. Syrian and Armenian hamsters differ in serum amyloid A (SAA) gene expression: identification of novel Syrian hamster SAA subtypes. J Immunol 1993; 153: 5361–5370
   Google Scholar
• Coe J E, Ross M J. Amyloidosis and female protein in the Syrian hamster. concurrent regulation of sex hormones. J Exp Med 1991; 171: 1257–1267
   Web of Science ®Google Scholar
• Markwell MAK, Haas S M, Bieber B B, Tolbert N E. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 1978; 87: 206–210
   PubMed Web of Science ®Google Scholar
• Sipe J D, Gonnerman W A, Loose L D, Knapschafer G, Xie W-J, Franzblau C. Direct binding enzyme-linked immunosorbant assay (ELISA) for serum amyloid A (SAA). J Lnmunol Methods 1989; 125: 125–135
   PubMed Web of Science ®Google Scholar
• Nicolosi R J, Herrera M G, El Lozy M, Hayes K C. Effect of dietary fat on hepatic metabolism of 14C-oleic acid and very low density lipoprotein triglyceride in the gerbil. J Nutrition 1976; 106: 1279–1285
   PubMed Web of Science ®Google Scholar
• Contreras M, Bale W F, Spar I L. Iodine monochloride (ICI) iodination techniques. Methods Enzymol 1977; 92: 277–292
   Google Scholar
• Esterbauer H, Jurgens G, Quehenberger O, Koller E. Autoxidation of human low density lipoprotein. J Lipid Res 1987; 28: 495–509
   PubMed Web of Science ®Google Scholar
• Hayes K C, Pronczuk A, Liang J-s. Differences in the plasma transport and tissue concentrations of tocopherols and tocotrienols: observations in humans and hamsters. Proc Soc Expl Biol Med 1993; 202: 353–359
   PubMed Web of Science ®Google Scholar
• Sipe J D. The molecular biology of interleukin 1 and the acute phase response. Adv Int Med 1989; 34: 1–20
   PubMedGoogle Scholar
• Sipe J D, Rokita H, de Beer F C. Cytokine regulation of the mouse SAA gene family. Acute Phase Proteins: Molecular Biology. Biochemistry, Clinical Application, A Mackiewicz, I Kushner, H Baumann. CRC Press, Boca Raton 1993; 511–525
   Google Scholar
• Feingold K R, Grunfeld C. Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo. J Clin Invest 1987; 80: 184–190
   PubMed Web of Science ®Google Scholar
• Feingold K R, Serio M K, Adi S, Moser A H, Grunfeld C. Tumor necrosis factor stimulates hepatic lipid synthesis and secretion. Endocrinology 1989; 124: 2336–2342
   PubMed Web of Science ®Google Scholar
• Feingold K R, Soued M, Adi S, Strapans I, Neese R, Shigena J, Doerrier W, Moser A H, Dinarello C A, Grunfeld C. Effects of interleukin-I on lipid metabolism in the rat: Similarities to and differences from tumor necrosis factor. Arterioscler Thromb 1991; 11: 495–500
   PubMedGoogle Scholar
• Argiles J M, Lopez-Soriano F J, Evans R D, Williamson D H. Interleukin-l and lipid metabolism in the rat. Biochem J 1989; 259: 673–678
   PubMed Web of Science ®Google Scholar
• Hermos ARMM, Sweep CGJ, Demacker PNM, van der Meer MJM, Kloppenborg PWC, van der Meer JWM. Continuous infusion of interleukin-l-beta in rats induces a profound fall in plasma levels of cholesterol and triglycerides. Arterioscler Thromb 1992; 12: 1036–1043
   PubMedGoogle Scholar
• Memon R A, Grunfeld C, Moser A H, Feingold K R. Tumor necrosis factor mediates the effect of endotoxin on cholesterol and triglyceride metabolism in mice. Endocrinology 1993; 132: 2246–2253
   PubMed Web of Science ®Google Scholar
• Feingold K R, Hardardottir I, Memon R, Krul EJT, Moser A H, Taylor J M, Grunfeld C. Effect of endotoxin on cholesterol biosynthesis and distribution in serum lipoproteins in Syrian hamsters. J Lipid Res 1993; 342: 147–2158
   Google Scholar
• Tall A R, Small D M. Plasma high-density lipoproteins (Review). New Engl J Med 1978; 299: 1232–1236
   PubMed Web of Science ®Google Scholar
• Feingold K R, Strapans I, Memon R A, Moser A H, Shigenaga J K, Doerrler W, Dinarello C A, Grunfeld C. Endo-toxin rapidly induces changes in lipid metabolism that pro-duce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. J Lipid Res 1992; 33: 1765–1776
   PubMed Web of Science ®Google Scholar
• Xu N, Nilsson A. Endotoxin inhibits catabolism of LDL in vivo: an experimental study in the rat. Scand. J Clin Lab Invest 1996; 56: 53–61
   PubMed Web of Science ®Google Scholar
• Williams K I, Higgs G A. Eicosanoids and inflammation. J Pathol 1988; 156: 101–110
   PubMed Web of Science ®Google Scholar
• Polacek D, Byrne R E, Fleas G M, Scanu A M. In vitro proteolysis of human plasma low density lipoproteins by an elastase released from human blood polymorphonuclear cells. J Biol Chem 1986; 261: 2057–2063
   PubMed Web of Science ®Google Scholar
• Lavie G, Zucker-Franklin D, Franklin E C. Degradation of serum amyloid A by surface associated enzymes of human blood monocytes. J Exp Med 1978; 148: 1020–1031
   PubMed Web of Science ®Google Scholar
• Silverman S L, Cathcart E S, Skinner M, Cohen A S. Degradation of SAA protein by activated polymorphonuclear leukocytes: participation of granulocyte elastase. Immunol 1982; 46: 737–744
   PubMed Web of Science ®Google Scholar
• Elliott Bryant R, Liang J-s, Sipe J D, Cathcart E S. Degradation of serum amyloid A in amyloid-susceptible and amyloid-resistant mouse strains. Scand Jlmmunol 1996; 44: 222–228
   Web of Science ®Google Scholar
• Liang J-s, Sipe J D. Recombinant human serum amyloid A (apoSAAP) binds cholesterol and modulates cholesterol flux. J Lipid Res 1995; 36: 37–46
   PubMed Web of Science ®Google Scholar